Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of DT678 tablets for antiplatelet therapy after PCI
CTR20252776Phase 2Active
- Sponsor
- China Resources Double-Crane Pharmaceutical
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DT678 in coronary arteriosclerosis, atherothrombosis, sponsored by China Resources Double-Crane Pharmaceutical. Started Nov 2025; status: active.
02
Drugs
DT678
03
Conditions
coronary arteriosclerosisatherothrombosis
Beyond the preview
Go deeper on CTR20252776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252776.